Literature DB >> 1343440

Antifungal therapy: from amphotericin B to present.

W E Dismukes1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 1343440      PMCID： PMC2376613     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN： 0065-7778


× No keyword cloud information.
  21 in total

Review 1.  Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature.

Authors:  L J Wheat; P A Connolly-Stringfield; R L Baker; M F Curfman; M E Eads; K S Israel; S A Norris; D H Webb; M L Zeckel
Journal:  Medicine (Baltimore)       Date:  1990-11       Impact factor: 1.889

Review 2.  Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses.

Authors:  S M Grant; S P Clissold
Journal:  Drugs       Date:  1990-06       Impact factor: 9.546

3.  A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis.

Authors:  J E Bennett; W E Dismukes; R J Duma; G Medoff; M A Sande; H Gallis; J Leonard; B T Fields; M Bradshaw; H Haywood; Z A McGee; T R Cate; C G Cobbs; J F Warner; D W Alling
Journal:  N Engl J Med       Date:  1979-07-19       Impact factor: 91.245

4.  Itraconazole therapy for chronic coccidioidal meningitis.

Authors:  R M Tucker; D W Denning; B Dupont; D A Stevens
Journal:  Ann Intern Med       Date:  1990-01-15       Impact factor: 25.391

Review 5.  Amphotericin B: 30 years of clinical experience.

Authors:  H A Gallis; R H Drew; W W Pickard
Journal:  Rev Infect Dis       Date:  1990 Mar-Apr

Review 6.  Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses.

Authors:  S M Grant; S P Clissold
Journal:  Drugs       Date:  1989-03       Impact factor: 9.546

7.  Treatment of coccidioidal meningitis with fluconazole.

Authors:  R M Tucker; J N Galgiani; D W Denning; L H Hanson; J R Graybill; K Sharkey; M R Eckman; C Salemi; R Libke; R A Klein
Journal:  Rev Infect Dis       Date:  1990 Mar-Apr

8.  A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group.

Authors:  W G Powderly; M S Saag; G A Cloud; P Robinson; R D Meyer; J M Jacobson; J R Graybill; A M Sugar; V J McAuliffe; S E Follansbee
Journal:  N Engl J Med       Date:  1992-03-19       Impact factor: 91.245

Review 9.  Antifungal agents used for deep-seated mycotic infections.

Authors:  C L Terrell; C E Hughes
Journal:  Mayo Clin Proc       Date:  1992-01       Impact factor: 7.616

10.  Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes.

Authors:  D S Loose; P B Kan; M A Hirst; R A Marcus; D Feldman
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.